Organogenesis Holdings Inc. (ORGO) has a MoatMap StockRank of 69/100 based on Quality (64/100), Value (58/100), and Momentum (28/100) factor scores. The current signal is BUY. Organogenesis Holdings, a healthcare regenerative medicine company, operates in a high-risk biotech sector dependent on R&D, clinical success, and regulatory approvals. This business model does not align with the fund's preference for quality compounders with predictable owner earnings and durable moats that are driven by broad macro inflections.